CACNA1C and schizophrenia: Among the CACNA1C variants, rs1006737 and rs4765905 demonstrated high predicted regulatory activity, with RegulomeDB scores of 1f and 2b, respectively, and have been consistently implicated in neuropsychiatric disorders such as autism, schizophrenia, and epilepsy [26].